|Catalog Number||Pack Size||List Price*||Quantity|
|HY-13463-10MMO||10 mM * 1 mL||Inquire|
* CHF, excl. 7.7% VAT and shipping costs
You are currently not logged in.
Please register to see prices including your discount. Registration may take up to 24h. For guest orders the standard discount of your institution will apply and discounts are visible on the order confirmation.
AKR-501; E5501; YM477
Avatrombopag (AKR-501) is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist (EC50=3.3 nM). Avatrombopag mimics the biological activities of TPO. Avatrombopag increases platelet production by activating the intracellular signaling system, and promotes production of platelets and megakaryocytes from hemopoietic precursor cells. Avatrombopag is a substrate of cytochrome P450 (CYP) 2C9 and CYP3A.
|Format||Solubility: DMSO : ≥ 32 mg/mL (49.26 mM)|
|Grade||Clinical information: Launched|
|Storage Conditions||Please store the product under the recommended conditions in the Certificate of Analysis.|
|Tech. Data Sheet||View datasheet|
|Link To Supplier||http://www.medchemexpress.com|
|Material Safety Data Sheet||Download PDF|